Company profile: Biorasi
1.1 - Company Overview
Company description
- Provider of contract research services for complex clinical trials, offering safety and pharmacovigilance (medical coding, case processing, data monitoring, safety management, annual reporting), clinical trial rescue (patient recruitment, site activation, logistical coordination), CAR T-cell therapy trial management (cell collection, modification, reinfusion), and precision medicine through pharmacogenomics.
Products and services
- CAR T-Cell Therapy Trials: Manages complex CAR T-cell therapy trials with logistical support for cell collection, modification, and reinfusion
- Clinical Trial Rescue: Delivers time-sensitive turnaround for struggling clinical trials by accelerating patient recruitment, expediting site activation, and logistical coordination ensuring timely completion
- Safety and Pharmacovigilance Solutions: Executes end-to-end clinical safety activities, covering medical coding, case processing, data monitoring, safety management, and preparation of annual reporting
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biorasi
Clinical Trial Service
HQ: The Netherlands
Website
- Description: Provider of clinical research services as a private clinical research organization based in Losser.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Trial Service company profile →
Lindus Health
HQ: United Kingdom
Website
- Description: Provider of end-to-end clinical trial services for the life sciences sector, covering ethics/IRB submissions, trial monitoring, data management, biostatistics, regulatory and payor affairs; AI-assisted trial design; direct patient recruitment; a clinical software platform (EDC, eSource, CTMS); CDISC SDTM data delivery; site and feasibility capabilities; and patient concierge support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lindus Health company profile →
Casimir
HQ: United States
Website
- Description: Provider of virtual trials and remote assessments and qualitative research centered on the patient experience, capturing the real-world impact of treatment interventions on patient quality-of-life through smart outcome measures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Casimir company profile →
Peptido
HQ: Germany
Website
- Description: Provider of GMP-compliant synthesis of pharmaceutical active ingredients, delivering services from lab-scale and pilot quantities to industrial-scale production for the pharmaceutical industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Peptido company profile →
Seqens
HQ: France
Website
- Description: Provider of integrated pharmaceutical synthesis and specialty ingredients, delivering market responsiveness and tailor-made solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seqens company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biorasi
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biorasi
2.2 - Growth funds investing in similar companies to Biorasi
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biorasi
4.2 - Public trading comparable groups for Biorasi
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →